A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen.

The FTC analyzed data for 51 specialty generic drugs dispensed from 2017-2022 for patients with commercial insurance or Medicare Part D plans managed by CVS Caremark, Express Scripts and OptumRx.

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

The biggest pharmacy benefit managers have made efforts to improve relationships with pharmacies, health insurers, employers ...

A giant healthcare company is suing the State of Minnesota over a state law that is supposed to protect small pharmacies in ...

The term Web Client Runtime Security (WCRS) was coined by the authors to highlight the security or possible malicious ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country's healthcare system.

FTC said the "Big 3 PBMs" — CVS’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx — imposed markups of hundreds to thousands of percent on critical drugs, including those ...